IQVIA HOLDINGS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 203.20 USD | -1.57% |
|
+0.70% | -12.18% |
| Dec. 10 | IQVIA Holdings Inc. - Analyst/Investor Day | |
| Dec. 04 | HSBC Adjusts Price Target on IQVIA Holdings to $270 From $290 | MT |
Chart calendar Iqvia Holdings Inc.
938da743ac9afdf4fc07806d2.OKkOMpqFtiWb8VjHKnYHVezNW5I376gKNhbawPPwhZk.b996dfux_GuvxgeSSzBWEqOLH_EHmO0_AVyquaqj0fJTm0lB2LbvVOydKw~e24dd89672fc6a322968979e51881b33
Upcoming events on Iqvia Holdings Inc.
Past events on Iqvia Holdings Inc.
| 2024-12-10 10:30 am | Investor Day |
| 2024-11-13 01:15 pm | UBS Global Healthcare Conference |
| 2024-10-31 09:00 am | Q3 2024 Earnings Call |
| 2024-10-31 07:00 am | Q3 2024 Earnings Release |
| 2024-09-04 10:00 am | Morgan Stanley Healthcare Conference |
| 2024-07-22 09:00 am | Q2 2024 Earnings Call |
| 2024-07-22 07:00 am | Q2 2024 Earnings Release |
| 2024-05-14 12:20 pm | BofA Securities Health Care Conference |
| 2024-05-02 09:00 am | Q1 2024 Earnings Call |
| 2024-05-02 07:00 am | Q1 2024 Earnings Release |
| 2024-04-16 09:00 am | Annual General Meeting |
| 2024-03-13 09:30 am | Barclays Global Healthcare Conference |
| 2024-02-29 09:30 am | Citi Unplugged Medtech and Life Sciences Access Day |
| 2024-02-14 09:00 am | Q4 2023 Earnings Call |
| 2024-02-14 07:00 am | Q4 2023 Earnings Release |
| 2023-11-29 10:50 am | Evercore ISI HealthCONx Conference |
| 2023-11-01 09:00 am | Q3 2023 Earnings Call |
| 2023-11-01 07:00 am | Q3 2023 Earnings Release |
| 2023-09-13 10:50 am | Baird Global Healthcare Conference |
| 2023-09-12 11:30 am | Morgan Stanley Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13 874 13 830 0.32% | 14 410 14 387 0.16% | 14 984 14 910 0.5% | 15 387 | 16 185 | 17 088 |
|
EBITDA Million USD | Released Forecast Spread | 3 022 2 993 0.98% | 3 346 3 342 0.13% | 3 569 3 566 0.08% | 3 692 | 3 905 | 4 169 |
|
EBIT Million USD | Released Forecast Spread | 2 591 2 537 2.11% | 2 779 2 846 -2.36% | 3 050 3 028 0.72% | 3 125 | 3 328 | 3 535 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 128 1 089 3.61% | 1 363 1 540 -11.51% | 1 459 1 518 -3.9% | 1 619 | 1 875 | 2 203 |
|
Net income Million USD | Released Forecast Spread | 966 922 4.75% | 1 091 1 219 -10.47% | 1 358 1 226 10.77% | 1 333 | 1 527 | 1 784 |
|
EPS USD | Released Forecast Spread | 4,95 4,73 4.6% | 5,72 6,35 -9.97% | 7,29 6,53 11.7% | 7,36 | 8,34 | 9,57 |
| Announcement Date | 15/02/22 | 10/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 652 3 608 1.22% | 3 728 3 708 0.53% | 3 736 3 777 -1.08% | 3 868 3 797 1.88% | 3 737 3 705 0.86% | 3 814 3 790 0.64% | 3 896 3 857 1.01% | 3 934 | 3 882 | 3 988 | 4 047 | 4 192 | 4 115 | 4 199 | 4 294 |
|
EBITDA Million USD | Released Forecast Spread | 851 849 0.21% | 864 860 0.47% | 888 886 0.21% | 966 963 0.32% | 862 863 -0.16% | 887 884 0.38% | 939 937 0.25% | 996 | 908 | 930 | 995 | 1 067 | 984 | 1 021 | 1 061 |
|
EBIT Million USD | Released Forecast Spread | 721 723 -0.25% | 737 726 1.56% | 747 753 -0.86% | 821 821 0.02% | 738 728 1.42% | 751 746 0.62% | 788 794 -0.76% | 846 | 766 | 793 | 840 | 915 | 831 | 864 | 914 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 362 363 -0.33% | 375 368 1.79% | 349 379 -7.98% | 373 430 -13.34% | 340 358 -4.97% | 436 372 17.27% | 349 455 -23.3% | 495 | 396 | 423 | 466 | 541 | 459 | 487 | 526 |
|
Net income Million USD | Released Forecast Spread | 289 290 -0.3% | 297 283 4.93% | 303 294 3.04% | 469 333 40.65% | 288 283 1.75% | 363 304 19.37% | 285 359 -20.66% | 389 | 320 | 343 | 377 | 438 | 369 | 393 | 426 |
|
EPS USD | Released Forecast Spread | 1,53 1,52 0.63% | 1,59 1,50 6.2% | 1,63 1,58 3.37% | 2,54 1,77 43.5% | 1,56 1,48 5.29% | 1,97 1,62 21.73% | 1,55 1,92 -19.36% | 2,07 | 1,72 | 1,89 | 2,04 | 2,40 | 2,08 | 2,23 | 2,42 |
| Announcement Date | 27/04/23 | 01/08/23 | 01/11/23 | 14/02/24 | 02/05/24 | 22/07/24 | 31/10/24 | - | - | - | - | - | - | - | - |
More events
Past sector events for Iqvia Holdings Inc.
| 2024-11-27 | FORMYCON AG: Q3 2024 Earnings Release |
| 2024-11-20 07:00 am | SEPTERNA, INC.: Q3 2024 Earnings Release |
| 2024-11-20 02:00 am | GENUS PLC: Q1 2025 Sales and Revenue Release - Trading Update |
| 2024-11-19 | MESOBLAST LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-11-14 08:00 am | ARRIVENT BIOPHARMA, INC.: Q3 2024 Earnings Release |
| 2024-11-14 08:00 am | SILENCE THERAPEUTICS PLC: Q3 2024 Earnings Release |
| 2024-11-14 02:00 am | BIOARCTIC AB: Q3 2024 Earnings Release |
| 2024-11-13 | VORONOI, INC.: Q3 2024 Earnings Release |
| 2024-11-13 | GNI GROUP LTD.: Q3 2024 Earnings Release |
| 2024-11-13 04:10 pm | PHARVARIS N.V.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IQV Stock
- Calendar Iqvia Holdings Inc.